Navigation Links
Kayentis, the Leading Provider of the Unique "Paper-Based e-Trial" Solution, has been Retained for Six New Clinical Studies in the US Market
Date:9/23/2009

Kayentis, the global leader of digital pen and paper technology and the unique provider of "paper-based e-trial" solution, today announced that it has been retained for six new clinical studies conducted in the US, therefore continuing and strengthening its expansion in North America.

Philadelphia, PA / Gif sur Yvette, France (PRWEB) September 22, 2009 -- Kayentis offers Clin'Form, the optimal paper-based e-data capture solution for clinical trials. Clin'Form combines the best that the physical and the digital worlds have to offer. It is the easiest and most reliable data collection method for both patients and physicians (pen & paper), resulting in the highest quality of data captured. These benefits are combined with all the advantages of electronic data management (real-time access, data sharing, audit trail functionalities, alerts, etc.); while providing accurate timestamps and significantly streamlining clinical trial costs.

Six US pharmaceutical companies have retained Clin'Form to run their clinical studies, involving investigators and patients (CRF and PRO). "We are much honored to have been retained by our new sponsors. Clin'Form, our Digital Pen and Paper based data capture solution, helps them improve the quality of the data captured and significantly reduces the steps required for the deployment of a study - and in doing so simultaneously saves time and costs dramatically" comments Guy Maestre, Kayentis Vice President, North American Operations. "It provides a decisive advantage for life sciences companies in the implementation of their clinical trials while end-users (investigators, CRAs, patients) benefit from a very natural way to capture clinical data."

Clin'Form has been successfully deployed in studies conducted in more than 40 countries, in over forty different languages, and involving over 50 000 patients across all continents.

ABOUT KAYENTIS
Kayentis provides software solutions dedicated to each stage of a drug's life cycle development. It offers key solutions to collect, display, share and archive information and clinical data. Kayentis Clin'Form solution, enabling Anoto functionality, is the optimal paper-based e-data capture solution for clinical trials.
Kayentis is a member of Pennsylvania BIO and BIO New Jersey. Kayentis is an Anoto Platinum Partner, an Oracle Partner and an HP Solution Business Partner.

To discover more about this unique solution please visit www.kayentis.com.

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2924304.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer Dr. ... colleagues, skilled nursing facility medical directors and other clinicians at various events in ... , "At many of these conferences we get to educate other physicians, facility ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... Md. , Sept. 22, 2017  As the ... Republican Senators Bill Cassidy (R-LA) and ... Information notes that the medical device industry is in ... medical device tax, the 2.3% excise tax on medical ... But they also want covered patients, increased visits and ...
Breaking Medicine Technology: